{
  "figure_01": "(a) Milestones of mental health services and research in China in the past three decades. (b) Mental health clinics annual visits and facilities increase from 2007 to 2018. Data from the China Health Statistical Yearbook (National Health Commission, 2019). (c) Number of papers published in international peer-reviewed journals in the neuroscience field for four countries (USA, China, UK and Germany) from 1996 to 2019. (d) Number of papers published in neuroscience field (circle size) in top 20 countries with the highest H index (y-axis) in 2019. Data of (c–d) are from https://www.scimagojr.com/.",
  "figure_02": "Reviews and meta-analyses on (a) genetic research and (b) neuroimaging research in China systematically retrieved from PubMed, Scopus and CNKI databases. The search terms were: [‘mental disorder’ OR psychiatr* OR schizophrenia OR ‘affective disorder’ OR depressi* OR ‘bipolar disorder’ OR ‘anxiety disorder’ OR autism OR ADHD OR ‘obsessive compulsive disorder’ OR ‘drug abuse’ OR ‘substance abuse’]\nAND\n[China[Title/Abstract]]\nAND\n[‘genetic’ OR ‘GWAS’ OR ‘methylation’ OR ‘gene expression’] for genetic research; [‘mental disorder’ OR psychiatr* OR schizophrenia OR ‘affective disorder’ OR depressi* OR ‘bipolar disorder’ OR ‘anxiety disorder’ OR autism OR ADHD OR ‘obsessive compulsive disorder’ OR ‘drug abuse’ OR ‘substance abuse’]\nAND\n[China[Title/Abstract]]\nAND\n[‘neuroimaging’ OR ‘brain imaging’ OR ‘magnetic resonance imaging’ OR MRI OR ‘positron emission tomography’ OR PET] for neuroimaging research. Limited to publication type: Meta-Analysis, Review and Systematic Review. Exclusion criteria include no-fulltext, not a journal article, not about genetic/neuroimaging research, not about psychiatric disorders or not conducted in Chinese populations.",
  "figure_03": "Representative studies and research applications in psychiatric disorders. (a) Lifetime and 12-month prevalence of mental disorders in adulthood reported by Huang et al. (2016). (b) Genome-wide associations in the Chinese schizophrenia cases (lower) and in the combined sample (upper) of the Psychiatry Genomics Consortium (PGC2) and Chinese populations (43 175 cases; 65 166 controls) (Li et al., 2017a, 2017b). (c) Implications to disease neuropathology and clinical application from neuroimaging studies of major depressive disorder (Cheng et al., 2016), schizophrenia (Du et al., 2021) and autism (Dai et al., 2021). Figures reproduced with permission."
}